Alfred Hansel
Directeur Général chez oncgnostics GmbH
Profil
Alfred Hansel is the founder and Chief Executive Officer of oncgnostics GmbH, a company founded in 2012.
He holds a doctorate degree from the University of Freiburg and an undergraduate degree from Friedrich-Alexander University of Erlangen-Nuremberg.
Postes actifs de Alfred Hansel
| Sociétés | Poste | Début |
|---|---|---|
oncgnostics GmbH
 oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Directeur Général | 01/02/2012 |
Formation de Alfred Hansel
| Friedrich-Alexander University of Erlangen-Nuremberg | Undergraduate Degree |
| University of Freiburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
oncgnostics GmbH
oncgnostics GmbH Medical SpecialtiesHealth Technology oncgnostics GmbH offers cervical cancer diagnostic products and services. It engages in applying tumor-specific DNA methylation markers for cancer diagnosis and screening. The firm develops, based on proprietary epigenetic biomarkers, molecular in vitro diagnostic tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. The company was founded by Matthias Dürst, Kerstin Brox, Martina Schmitz and Alfred Hansel in February 2012 and is headquartered in Jena, Germany. | Health Technology |
